Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for urinary tract infection
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
[Comparative effectiveness of carbapenems and alternative antibiotics for the treatment of bacteraemia and/or urinarytractinfectious disease by Enterobacteriaceae producing extended-spectrum á-lactamase] [Comparative effectiveness of carbapenems and alternative antibiotics for the treatment of bacteraemia and/or urinarytractinfectious disease by Enterobacteriaceae producing extended-spectrum β-lactamase] [Comparative effectiveness of carbapenems and alternative antibiotics for the treatment (...) of bacteraemia and/or urinarytractinfectious disease by Enterobacteriaceae producing extended-spectrum β-lactamase] Dong Ah Park, Jinnie Rhee, Na Rae Lee, Ji Jeong Park, Soo Kyung Son, Kyong Ran Peck, Su Yeun Moon, Eun-Jeong Joo, Jae-Ki Choi, Jae-Hoon Ko Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Dong Ah Park, Jinnie Rhee, Na Rae Lee, Ji Jeong
and treatment options. Nat Rev Microbiol. 2015;13(5):269-84. doi: 10.1038/nrmicro3432. 9. Goilav B, Kaskel F. Urinarytractinfection in children [Internet]. London: BMJ Publishing Group Ltd. 2015 [cited 2016 Jan 20]. Available from: Best Practice. 10. Foxman, B. Urinarytractinfection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North Am. 2014;28: 1 –13. 11. Nicolle LE et al. Infectious Diseases Society of America guidelines for the diagnosis (...) of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev. 2015;11;11:CD000491. doi: 10.1002/14651858.CD000491.pub3. NIHR Diagnostic Evidence Cooperative Oxford www.oxford.dec.nihr.ac.uk 19. Hooton TM, Bradley SF, Cardenas DD et al. Diagnosis, prevention, and treatment of catheter-associated urinarytractinfection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010. 50(5):625-63. 20. Leone M, Perrin
Detection of ctx-M gene in ESBL-producing E. coli strains isolated from urinarytractinfection in Semnan, Iran The incidence of urinarytractinfections caused by Extended-Spectrum Beta Lactamase (ESBL) producing Escherichia coli (E. coli) strains due to long term and overuse of broad-spectrum cephalosporine is on the rise. CTX beta-lactamase type, a broad-spectrum beta-lactamase, has been expanding in many countries. The ctx gene is harbored on a plasmid that is spread between (...) Enterobacteriaceae family, especially in E. coli. The aim of this study was to determine the pattern of antimicrobial resistance and investigate the prevalent ESBL phenotype and the ctx-M gene in E. coli isolated from patients with urinarytractinfections (UTI) in Semnan.A cross sectional study was performed on 109 strains of E. coli isolated from the urine culture of patient suffering from a UTI referred to Shafa hospital (Semnan, Iran) during March-July 2015. Antimicrobial susceptibility testing was applied
Rapid Urinalysis for Detecting UrinaryTractInfections: Cost-Effectiveness Rapid Urinalysis for Detecting UrinaryTractInfections: Cost-Effectiveness | CADTH.ca Find the information you need Rapid Urinalysis for Detecting UrinaryTractInfections: Cost-Effectiveness Rapid Urinalysis for Detecting UrinaryTractInfections: Cost-Effectiveness Published on: June 7, 2016 Project Number: RB0994-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type (...) : Report Question What is the cost-effectiveness of rapid urinalysis for detecting bacterial infection in patients with suspected urinarytractinfections? Key Message No relevant literature was identified regarding the cost-effectiveness of rapid urinalysis for detecting bacterial infection in patients with suspected urinarytractinfections. Tags bacterial load, bacteriuria, cystitis, diagnostic tests, kidney, urinalysis, urinarytractinfections, urine, Diagnostic, Reagent Kits, UTI, UTIs
A Program to Prevent Catheter-Associated UrinaryTractInfection in Acute Care. Catheter-associated urinarytractinfection (UTI) is a common device-associated infection in hospitals. Both technical factors--appropriate catheter use, aseptic insertion, and proper maintenance--and socioadaptive factors, such as cultural and behavioral changes in hospital units, are important in preventing catheter-associated UTI.The national Comprehensive Unit-based Safety Program, funded by the Agency (...) ). Multilevel negative binomial models were used to assess changes in catheter use and catheter-associated UTI rates.Data were obtained from 926 units (59.7% were non-ICUs, and 40.3% were ICUs) in 603 hospitals in 32 states, the District of Columbia, and Puerto Rico. The unadjusted catheter-associated UTI rate decreased overall from 2.82 to 2.19 infections per 1000 catheter-days. In an adjusted analysis, catheter-associated UTI rates decreased from 2.40 to 2.05 infections per 1000 catheter-days (incidence
Catheter-Associated UrinaryTractInfections - Turning the Tide. 27248624 2016 06 13 2018 12 02 1533-4406 374 22 2016 Jun 02 The New England journal of medicine N. Engl. J. Med. Catheter-Associated UrinaryTractInfections--Turning the Tide. 2168-9 10.1056/NEJMe1604647 Huang Susan S SS From the Division of Infectious Diseases and Health Policy Research Institute, University of California Irvine School of Medicine, Irvine. eng Editorial Comment United States N Engl J Med 0255562 0028-4793 AIM IM (...) N Engl J Med. 2016 Jun 2;374(22):2111-9 27248619 Catheter-Related Infections prevention & control Cross Infection prevention & control Humans Urinary Catheterization statistics & numerical data UrinaryTractInfections prevention & control 2016 6 2 6 0 2016 6 2 6 0 2016 6 14 6 0 ppublish 27248624 10.1056/NEJMe1604647
UrinaryTractInfections in Older Men. 27248641 2016 06 02 2018 12 02 1533-4406 374 22 2016 06 02 The New England journal of medicine N. Engl. J. Med. UrinaryTractInfections in Older Men. 2192 10.1056/NEJMc1603508 Schaeffer Anthony J AJ Nicolle Lindsay E LE eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Anti-Bacterial Agents AIM IM N Engl J Med. 2016 Feb 11;374(6):562-71 26863357 N Engl J Med. 2016 Jun 2;374(22):2191 27248642 N Engl J Med. 2016 Jun 2;374(22):2191-2 27248643 (...) Anti-Bacterial Agents therapeutic use Humans Male Prostatitis diagnosis UrinaryTractInfections diagnosis 2016 6 2 6 0 2016 6 2 6 0 2016 6 3 6 0 ppublish 27248641 10.1056/NEJMc1603508 10.1056/NEJMc1603508#SA3
UrinaryTractInfections in Older Men. 27248642 2016 06 02 2018 12 02 1533-4406 374 22 2016 06 02 The New England journal of medicine N. Engl. J. Med. UrinaryTractInfections in Older Men. 2191 10.1056/NEJMc1603508 Wise Gilbert J GJ Weill Cornell Medicine, New York, NY email@example.com. eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Anti-Bacterial Agents AIM IM N Engl J Med. 2016 Feb 11;374(6):562-71 26863357 N Engl J Med. 2016 Jun 2;374(22):2192 27248641 Anti (...) -Bacterial Agents therapeutic use Humans Male Prostatitis diagnosis UrinaryTractInfections diagnosis 2016 6 2 6 0 2016 6 2 6 0 2016 6 3 6 0 ppublish 27248642 10.1056/NEJMc1603508 10.1056/NEJMc1603508#SA1
UrinaryTractInfections in Older Men. 27248643 2016 06 02 2018 12 02 1533-4406 374 22 2016 06 02 The New England journal of medicine N. Engl. J. Med. UrinaryTractInfections in Older Men. 2191-2 10.1056/NEJMc1603508 Etienne Manuel M Rouen University Hospital, Rouen, France firstname.lastname@example.org. Galperine Tatiana T Lille University Hospital, Lille, France. Caron François F Rouen University Hospital, Rouen, France. eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Anti (...) -Bacterial Agents AIM IM N Engl J Med. 2016 Feb 11;374(6):562-71 26863357 N Engl J Med. 2016 Jun 2;374(22):2192 27248641 Anti-Bacterial Agents therapeutic use Humans Male Prostatitis diagnosis UrinaryTractInfections diagnosis 2016 6 2 6 0 2016 6 2 6 0 2016 6 3 6 0 ppublish 27248643 10.1056/NEJMc1603508 10.1056/NEJMc1603508#SA2
Complicated urinarytractinfections: ceftolozane/tazobactam Complicated urinary tr Complicated urinarytractinfections: act infections: ceftolozane/tazobactam ceftolozane/tazobactam Evidence summary Published: 9 June 2016 nice.org.uk/guidance/esnm74 pathways K Ke ey points from the e y points from the evidence vidence The content of this evidence summary was up-to-date in June 2016. See summaries of product characteristics (SPCs), British national formulary (BNF) or the MHRA or NICE websites (...) for up- to-date information. Summary In a randomised controlled trial (RCT) in adults with complicated urinarytractinfections or acute pyelonephritis (ASPECT-cUTI), an intravenous (IV) infusion of ceftolozane/tazobactam was found to be non-inferior to IV levofloxacin for the composite outcome of microbiological eradication of all baseline uropathogens and clinical cure. In 2 RCTs in people receiving ceftolozane/tazobactam for complicated urinarytract or intra-abdominal infections (ASPECT-cUTI
Urinary alkalisation for symptomatic uncomplicated urinarytractinfection in women. Uncomplicated urinarytractinfection (UTI) is the most common bacterial infection in women, characterised by dysuria and urinary frequency. Urinary alkalisers are widely used in some countries for the symptomatic treatment of uncomplicated UTI, and they are recommended in some national formularies. However, there is a lack of empirical evidence to support their use for UTI and some healthcare guidelines advise (...) against their use.We aimed to look at the benefits and harms of the use of urinary alkalisers for the treatment of uncomplicated UTIs in adult women.We searched the Cochrane Kidney and Transplant Specialised Register to 19 January 2016 through contact with the Trials Search Co-ordinator using search terms relevant to this review.All randomised controlled trials (RCTs) and quasi-RCTs on the use of (any) urinary alkalisers (either exclusively or non-exclusively) for the symptomatic treatment
UrinaryTractInfections in Older Men. 26863357 2016 02 24 2016 06 02 1533-4406 374 6 2016 Feb 11 The New England journal of medicine N. Engl. J. Med. CLINICAL PRACTICE. UrinaryTractInfections in Older Men. 562-71 10.1056/NEJMcp1503950 Schaeffer Anthony J AJ Nicolle Lindsay E LE eng Journal Article Review United States N Engl J Med 0255562 0028-4793 0 Anti-Bacterial Agents AIM IM N Engl J Med. 2016 Jun 2;374(22):2192 27248641 N Engl J Med. 2016 Jun 2;374(22):2191-2 27248643 N Engl J Med. 2016 (...) Jun 2;374(22):2191 27248642 J Urol. 2016 Aug;196(2):442-3 27479385 Age Factors Aged Anti-Bacterial Agents therapeutic use Bacteriuria diagnosis Diagnosis, Differential Escherichia coli isolation & purification Humans Male Practice Guidelines as Topic Prostatitis diagnosis drug therapy UrinaryTractInfections diagnosis drug therapy Urine microbiology 2016 2 11 6 0 2016 2 11 6 0 2016 2 26 6 0 ppublish 26863357 10.1056/NEJMcp1503950
UrinaryTractInfection 1 Quality Department Guidelines for Clinical Care Ambulatory UrinaryTractInfection Guideline Team Team Leader Steven E Gradwohl, MD General Medicine Team Members Catherine M Bettcher, MD Family Medicine Carol E Chenoweth, MD Infectious Diseases R Van Harrison, PhD Medical Education Lauren B Zoschnick, MD Obstetrics & Gynecology Initial Release June, 1999 Most Recent Major Update May, 2011 Interim/Minor Revision September, 2016 Ambulatory Clinical Guidelines Oversight (...) and Endorsement Drafts of this guideline were reviewed in clinical conferences and by distribution for comment within departments and divisions of the University of Michigan Medical School to which the content is most relevant: Family Medicine, General Medicine, General Obstetrics & Gynecology, and Infectious Diseases. The Executive Committee for Clinical Affairs of the University of 8 UMHS UrinaryTractInfection Guideline, September 2016 Michigan Hospitals and Health Centers endorsed the final version
UrinaryTractInfection?Child Revised2016 ACR Appropriateness Criteria ® 1 UrinaryTractInfection–Child American College of Radiology ACR Appropriateness Criteria ® UrinaryTractInfection–Child Variant 1: Age 2 months and =6 years, first febrile urinarytractinfection with good response to treatment. Radiologic Procedure Rating Comments RRL* US kidneys and bladder 7 This procedure has a low yield, especially if US in the third trimester is normal. O Voiding cystourethrography 4 ?? Tc-99m (...) pertechnetate radionuclide cystography 4 ?? Tc-99m DMSA renal cortical scintigraphy 3 ??? Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate *Relative Radiation Level Variant 3: Age >6 years, first febrile urinarytractinfection with good response to treatment. Radiologic Procedure Rating Comments RRL* US kidneys and bladder 5 This procedure may be appropriate but there was disagreement among panel members on the appropriateness rating as defined by the panel’s
Systematic reviews on preventing catheter-associated urinarytractinfection Systematic reviews on preventing catheter-associated urinarytractinfection - NIPH Selected items added to basket Close Search for: Søk Meny Infectious diseases & Vaccines Close Mental & Physical health Close Environment & Lifestyle Close Health in Norway Close Quality & Knowledge Close Research & Access to data Close About NIPH Close Systematic reviews on preventing catheter-associated urinarytractinfection Authors (...) Related articles Have you found an error? Order Download: Key message The number of patients in hospitals and rehabilitation institutions at any time is large, and a considerable number of them need to use a urinary catheter. Catheter-associated urinarytractinfection may affect a large number of persons. The survey of prevalence of May 2015 from the Norwegian Institute of Public Health reported that 1.2 percent of patients in hospitals suffered from a urinarytractinfection. We have systematically
Fosfomycin (Fomicyt) - for the treatment of the following infections in adults and children including neonates: acute osteomyelitis; complicated urinarytractinfections; nosocomial lower respiratory tractinfections; bacterial meningitis; and bacteraemia Final Appraisal Recommendation Advice No: 3015 – October 2015 Fosfomycin (Fomicyt ® ) 40 mg/ml powder for solution for infusion Limited submission by Nordic Pharma UK Ltd Additional note(s): ? Fosfomycin (Fomicyt ® ) is appropriate (...) within NHS Wales for the treatment of the following infections in adults and children including neonates: acute osteomyelitis; complicated urinarytractinfections; nosocomial lower respiratory tractinfections; bacterial meningitis; and bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Fosfomycin (Fomicyt ® ) should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended